Inhibition of lipid peroxidation with the lazaroid U74500A attenuates ischemia-reperfusion injury in a canine orthotopic heart transplantation model

Journal of Thoracic and Cardiovascular Surgery

Volumn 112, Issue 4, 1996, Pages 1017-1026

  Tanoue, Y ^a   Morita, S ^a   Ochiai, Y ^a   Hisahara, M ^a   Masuda, M ^a   Kawachi, Y ^a   Tominaga, R ^a   Yasui, H ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

21 [4 [5,6 BIS(DIETHYLAMINO) 2 PYRIDYL] 1 PIPERAZINYL] 16ALPHA METHYLPREGNA 1,4,9(11) TRIENE 3,20 DIONE; ADENOSINE TRIPHOSPHATE; CREATINE KINASE; LAZAROID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BIOPSY; HEART MUSCLE ISCHEMIA; HEART PRESERVATION; HEART TRANSPLANTATION; LIPID PEROXIDATION; NONHUMAN; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 0029816663     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(96)70103-4     Document Type: Article

References (45)

1. JD Hosenpud RJ Novick TJ Breen B Keck P. Daily The Registry of the International Society for Heart and Lung Transplantation: twelfth official report—1995 J Heart Lung Transplant 14 1995 805 815
2. C Guarnieri F Flamigni CM Caldarera Role of oxygen in the cellular damage induced by re-oxygenation of hypoxic heart J Mol Cell Cardiol 12 1980 797 808
3. PS Rao MV Cohen HS Mueller Production of free radicals and lipid peroxides in early experimental myocardial ischemia J Mol Cell Cardiol 15 1983 713 716
4. FZ Meerson VE Kagan YP Kozlov LM Belkina YV Arkhipenko The role of lipid peroxidation in pathogenesis of ischemic damage and the antioxidant protection of the heart Basic Res Cardiol 77 1982 465 485
5. SR Jolly WJ Kane MB Bailie GD Abrams BR Lucchesi Canine myocardial reperfusion injury: its reduction by the combined administration of superoxide dismutase and catalase Circ Res 54 1984 277 285
6. GJ Gross NE Farber HF Hardman DC Warltier Beneficial actions of superoxide dismutase and catalase in stunned myocardium of dogs Am J Physiol 250 1986 H372 H377
7. JR Stewart SL Crute V Loughlin ML Hess LJ. Greenfield Prevention of free radical–induced myocardial reperfusion injury with allopurinol J THORAC CARDIOVASC SURG 90 1985 68 72
8. P Menasché C Grousset C Mouas A. Piwnica A promising approach for improving the recovery of heart transplants: prevention of free radical injury through iron chelation by deferoxamine J THORAC CARDIOVASC SURG 100 1990 13 21
9. JR Stewart WH Blackwell SL Crute V Loughlin LJ Greenfield ML. Hess Inhibition of surgically induced ischemia/reperfusion injury by oxygen free radical scavengers J THORAC CARDIOVASC SURG 86 1983 262 272
10. M Bernier DJ Hearse AS. Manning Reperfusion-induced arrhythmias and oxygen-derived free radicals: studies with “anti-free radical” interventions and a free radical–generating system in the isolated perfused rat heart Circ Res 58 1986 331 340
11. TP Ryan RC Steenwyk PG Pearson TW Petry Inhibition of in vitro lipid peroxidation by 21-aminosteroids: evidence for differential mechanisms Biochem Pharmacol 46 1993 877 884
12. JM Braughler JF Pregenzer RL Chase LA Duncan EJ Jacobsen JM McCall Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation J Biol Chem 262 1987 10438 10440
13. ED Hall PA Yonkers Attenuation of postischemic cerebral hypoperfusion by the 21-aminosteroid U74006F Stroke 19 1988 340 344
14. JM Braughler ED Hall EJ Jacobsen JM McCall ED Means The 21-aminosteroids: potent inhibitors of lipid peroxidation for the treatment of central nervous system trauma and ischemia Drug Future 14 1989 143 152
15. K Miyamoto S Morita T Nishida Pretreatment with lazaroid (U-74500A) prevents ischemic and reperfusion injury in blood-perfused rabbit hearts Surg Forum 45 1994 230 232
16. T Nishida S Morita K Miyamoto The effect of lazaroid (U74500A), a novel inhibitor of lipid peroxidation, on 24-hour heart preservation: a study based on a working model using cross-circulated blood perfused rabbit hearts Transplantation 61 1996 194 199
17. Y Tanoue S Morita Y Ochiai Successful twenty-four–hour canine lung preservation with the lazaroid U74500A J Heart Lung Transplant 15 1996 43 50
18. K Kinoshita M Oe K. Tokunaga Superior protective effect of low-calcium, magnesium-free potassium cardioplegic solution on ischemic myocardium: clinical study in comparison with St. Thomas' Hospital solution J THORAC CARDIOVASC SURG 101 1991 695 702
19. N Tanaka T Nozawa Y Yasumura S Futaki K Hiramoi H Suga Contractility to minimize oxygen consumption for constant work in dog left ventricle Heart Vessels 6 1990 9 20
20. T Nozawa Y Yasumura S Futaki Relation between oxygen consumption and pressure-volume area of in situ dog heart Am J Physiol 253 1987 H31 H40
21. J Bann ET van der Velde HG de Bruin Continuous measurement of left ventricular volume in animals and humans by conductance catheter Circulation 70 1984 812 823
22. RJ Applegate CP Cheng WC Little Simultaneous conductance catheter and dimension assessment of left ventricle volume in the intact animal Circulation 81 1990 638 648
23. RP Kelly R Tunin DA Kass Effect of reduced aortic compliance on cardiac efficiency and contractile function of in situ canine left ventricle Circ Res 71 1992 490 502
24. H Suga Ventricular energetics Physiol Rev 70 1990 247 277
25. DD Glower JA Spratt ND Snow Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work Circulation 71 1985 994 1009
26. max–end-diastolic volume relation in closed-chest dogs Circ Res 56 1985 808 815
27. WC Little CP Cheng M Mumma Y Igarashi J Vinten-Johansen WE Johnston Comparison of measures of left ventricular contractile performance derived from pressure-volume loops in conscious dogs Circulation 80 1989 1378 1387
28. WH Gaasch WE Battle AA Oboler JS Banas Jr HJ Levine Left ventricular stress and compliance in man: with special reference to normalized ventricular function curves Circulation 45 1972 746 762
29. H Suga R Hisano Y Goto O Yamada Y Igarashi Effect of positive inotropic agents on the relation between oxygen consumption and systolic pressure volume area in canine left ventricle Circ Res 53 1983 306 318
30. M Masuda K Yonenaga K Shiki S Morita H Kohno K. Tokunaga Myocardial protection in coronary occlusion by retrograde cardioplegic perfusion via the coronary sinus in dog: preservation of high-energy phosphates and regional function J THORAC CARDIOVASC SURG 92 1986 255 263
31. N Ohishi H Ohkawa A Miike T Tatano K Yagi A new assay method for lipid peroxides using a methylene blue derivative Biochem Int 10 1985 205 211
32. PA Southorn G Powis Free radicals in medicine. I. Chemical nature and biologic reactions Mayo Clin Proc 63 1988 381 389
33. R Aeba WA Killinger RJ Keenan Lazaroid U74500A as an additive to University of Wisconsin solution for pulmonary grafts in the rat transplant model J THORAC CARDIOVASC SURG 104 1992 1333 1339
34. M Ciuffi G Gentilini S Franchi-Micheli L. Zilletti Effect of 21-aminosteroid U74500A on rat brain cortex lipid peroxidation induced “in vivo” by iron-carbohydrate Biochem Pharmacol 47 1994 2181 2186
35. MA Levitt RE Sievers CL Wolfe Reduction of infarct size during myocardial ischemia and reperfusion by lazaroid U-74500A, a nonglucocorticoid 21-aminosteroid J Cardiovasc Pharmacol 23 1994 136 140
36. J Jacobsson R Sundberg HLR Rilo A Gasbarrini TE Starzl D Van-Thiel Protective effects of the lazaroid U74500A and lidoflazine on liver preservation with UW solution Transpl Int 6 1993 281 284
37. J Haynes Jr A Seibert JB Bass AE Taylor U74500A inhibition of oxidant-mediated lung injury Am J Physiol 259 1990 H144 H148
38. WA Killinger Jr DB Dorofi BA Keagy G Johnson Jr. Improvement of endothelial cell viability at 4º C by addition of lazaroid U74500A to preservation solutions Transplantation 53 1992 983 986
39. V Jeevanandam ML Barr JS Auteri University of Wisconsin solution versus crystalloid cardioplegia for human donor heart preservation: a randomized blinded prospective clinical trial J THORAC CARDIOVASC SURG 103 1992 194 199
40. DG Stein DC Drinkwater Jr H Laks Cardiac preservation in patients undergoing transplantation: a clinical trial comparing University of Wisconsin solution and Stanford solution J THORAC CARDIOVASC SURG 102 1991 657 665
41. A Kawai S Morita RL Kormos A clinical trial comparing University of Wisconsin solution and cold cardioplegic solution with load-independent mechanical parameters J Heart Lung Transplant 13 1994 150 156
42. H Kohno K Shiki Y Ueno K. Tokunaga Cold storage of the rat heart for transplantation: two types of solution required for optimal preservation J THORAC CARDIOVASC SURG 93 1987 86 94
43. M Amrani S Ledingham J Jayakumar Detrimental effects of temperature on the efficacy of the University of Wisconsin solution when used for cardioplegia at moderate hypothermia: comparison with the St. Thomas Hospital solution at 4º C and 20º C Circulation 86 Suppl 1992 II280 II288
44. P Mankad Z Slavik M. Yacoub Endothelial dysfunction caused by University of Wisconsin preservation solution in the rat heart: the importance of temperature J THORAC CARDIOVASC SURG 104 1992 1618 1624
45. JM Pearl H Laks DC Drinkwater Loss of endothelium-dependent vasodilatation and nitric oxide release after myocardial protection with University of Wisconsin solution J THORAC CARDIOVASC SURG 107 1994 257 264